Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.720
+0.130 (8.18%)
Aug 25, 2026, 1:41 PM EDT - Market open
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $124.67 million as of August 25, 2026. Its market cap has increased by 14.48% in one year.
Market Cap
124.67M
Enterprise Value
90.73M
1-Year Change
14.48%
Ranking
Category
Stock Price
$1.72
ChartMarket Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $124.67M, a decrease of -74.51%. That is a compound annual growth rate of -22.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 124.67M | 42.20% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 103.59M |
| Polaryx Therapeutics | 103.18M |
| Yarrow Bioscience | 101.99M |
| Cue Biopharma | 100.72M |
| Tenax Therapeutics | 100.24M |
| Adicet Bio | 98.92M |
| Kalaris Therapeutics | 98.79M |
| Pelthos Therapeutics | 97.66M |